(Q73635381)

English

Advanced glycosylation end products (AGEs), insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 (IGFBP-3) in patients with type 2 diabetes mellitus

scientific article published on 01 March 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751750%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Advanced glycosylation end products (AGEs), insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 (IGFBP-3) in patients with type 2 diabetes mellitus (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751750%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

type 2 diabetes

1 reference

based on heuristic

inferred from title

author name string

M E Garay-Sevilla

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751750%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

L E Nava

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751750%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J M Malacara

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751750%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

K Wróbel

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751750%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

K Wróbel

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751750%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

U Pérez

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751750%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 March 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751750%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

number of pages

8

1 reference

based on heuristic

inferred from page(s)

Diabetes - Metabolism: Research and Reviews

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751750%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751750%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751750%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

106-113

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751750%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Glucose and aging

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28200003%2F04%2916%3A2%3C106%3A%3AAID-DMRR88%3E3.0.CO%3B2-H

21 January 2018

Nonenzymatic glycosylation and the pathogenesis of diabetic complications

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28200003%2F04%2916%3A2%3C106%3A%3AAID-DMRR88%3E3.0.CO%3B2-H

21 January 2018

Diabetic neuropathy in elderly patients. What can be done?

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28200003%2F04%2916%3A2%3C106%3A%3AAID-DMRR88%3E3.0.CO%3B2-H

21 January 2018

Advanced glycosylation end products: a new disease marker for diabetes and aging

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28200003%2F04%2916%3A2%3C106%3A%3AAID-DMRR88%3E3.0.CO%3B2-H

21 January 2018

Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of advanced glycation-modified proteins to a conserved motif.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28200003%2F04%2916%3A2%3C106%3A%3AAID-DMRR88%3E3.0.CO%3B2-H

21 January 2018

Advanced glycosylation end products in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28200003%2F04%2916%3A2%3C106%3A%3AAID-DMRR88%3E3.0.CO%3B2-H

21 January 2018

Regulation and function of insulin-like growth factor-binding protein-1.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28200003%2F04%2916%3A2%3C106%3A%3AAID-DMRR88%3E3.0.CO%3B2-H

21 January 2018

[Decreased serum level of free bioavailable IGF-I in patients with diabetic retinopathy]

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28200003%2F04%2916%3A2%3C106%3A%3AAID-DMRR88%3E3.0.CO%3B2-H

21 January 2018

Binding proteins for the insulin-like growth factors: structure, regulation and function

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28200003%2F04%2916%3A2%3C106%3A%3AAID-DMRR88%3E3.0.CO%3B2-H

21 January 2018

Insulin-like growth factor (IGF)-binding proteins inhibit the biological activities of IGF-1 and IGF-2 but not des-(1-3)-IGF-1.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28200003%2F04%2916%3A2%3C106%3A%3AAID-DMRR88%3E3.0.CO%3B2-H

21 January 2018

Advanced glycosylation end products in diabetic renal and vascular disease

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28200003%2F04%2916%3A2%3C106%3A%3AAID-DMRR88%3E3.0.CO%3B2-H

21 January 2018

Diabetes mellitus and sexual ateliotic dwarfism: a comparative study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28200003%2F04%2916%3A2%3C106%3A%3AAID-DMRR88%3E3.0.CO%3B2-H

21 January 2018

A follow-up study of vascular disease in growth-hormone-deficient dwarfs with diabetes

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28200003%2F04%2916%3A2%3C106%3A%3AAID-DMRR88%3E3.0.CO%3B2-H

21 January 2018

Advanced glycosylation end products in continuous ambulatory peritoneal dialysis patients

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28200003%2F04%2916%3A2%3C106%3A%3AAID-DMRR88%3E3.0.CO%3B2-H

21 January 2018

Insulin-like growth factors. Studies in diabetics with and without retinopathy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28200003%2F04%2916%3A2%3C106%3A%3AAID-DMRR88%3E3.0.CO%3B2-H

21 January 2018

Is insulinlike growth factor I associated with diabetic retinopathy?

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28200003%2F04%2916%3A2%3C106%3A%3AAID-DMRR88%3E3.0.CO%3B2-H

21 January 2018

Growth hormone and diabetes mellitus. A review of sixty-three years of medical research and a glimpse into the future?

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28200003%2F04%2916%3A2%3C106%3A%3AAID-DMRR88%3E3.0.CO%3B2-H

21 January 2018

Insulin-infusion-pump treatment of diabetes: influence of improved metabolic control on plasma somatomedin levels

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28200003%2F04%2916%3A2%3C106%3A%3AAID-DMRR88%3E3.0.CO%3B2-H

21 January 2018

Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28200003%2F04%2916%3A2%3C106%3A%3AAID-DMRR88%3E3.0.CO%3B2-H

21 January 2018

Short-term changes in serum insulin-like growth factors (IGF) and IGF binding protein 3 after different modes of intravenous growth hormone (GH) exposure in GH-deficient patients

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28200003%2F04%2916%3A2%3C106%3A%3AAID-DMRR88%3E3.0.CO%3B2-H

21 January 2018

The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28200003%2F04%2916%3A2%3C106%3A%3AAID-DMRR88%3E3.0.CO%3B2-H

21 January 2018

Abnormal regulation of insulin-like growth factor binding proteins in adolescents with insulin-dependent diabetes.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28200003%2F04%2916%3A2%3C106%3A%3AAID-DMRR88%3E3.0.CO%3B2-H

21 January 2018

Age-Related Changes in Serum Insulin-Like Growth Factor-Binding Proteins in Women*

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28200003%2F04%2916%3A2%3C106%3A%3AAID-DMRR88%3E3.0.CO%3B2-H

21 January 2018

The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28200003%2F04%2916%3A2%3C106%3A%3AAID-DMRR88%3E3.0.CO%3B2-H

21 January 2018

Growth hormone-dependent insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28200003%2F04%2916%3A2%3C106%3A%3AAID-DMRR88%3E3.0.CO%3B2-H

21 January 2018

Serum insulin-like growth factors and their binding proteins in children with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28200003%2F04%2916%3A2%3C106%3A%3AAID-DMRR88%3E3.0.CO%3B2-H

21 January 2018

Insulin-like growth factor I plays a role in regulating erythropoiesis in patients with end-stage renal disease and erythrocytosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetes mellitus increases the severity of anemia in non-dialyzed patients with renal failure.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European best practice guidelines for the management of anaemia in patients with chronic renal failure. Working Party for European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Red cell life-span in nephritis and in hepatic cirrhosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Body fat mass and serum leptin levels influence epoetin sensitivity in patients with ESRD.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hormonal adjuvants for the treatment of renal anaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Erythropoietin depletion and anaemia in diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Type 2 diabetic patients with nephropathy show structural-functional relationships that are similar to type 1 disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anemia with erythropoietin deficiency occurs early in diabetic nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin-like growth factor-I in diabetes mellitus: its physiology, metabolic effects, and potential clinical utility

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The kidney and erythropoiesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in fluidity and composition of erythrocyte membranes and in composition of plasma lipids in type I diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo insulin effect on ATPase activities in erythrocyte membrane from insulin-dependent diabetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human erythropoietin: implications for nephrology

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of the anemia of progressive renal failure with recombinant human erythropoietin

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Worsening of anemia by angiotensin converting enzyme inhibitors and its prevention by antiestrogenic steroid in chronic hemodialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High serum erythropoietin levels are normalized during treatment of congestive heart failure with enalapril

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The inhibitory factors of hematopoiesis in chronic hemodialysis patients treated with recombinant human erythropoietin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enalapril-associated anemia in renal transplant recipients treated for hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Production of erythropoietic bursts by progenitor cells from adult human peripheral blood in an improved serum-free medium: role of insulinlike growth factor 1

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of orthostatic hypotension with erythropoietin

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Historical review on the use of recombinant human erythropoietin in chronic renal failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

R-HuEPO hyporesponsiveness--who and why?

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

R-HuEPO hyporesponsiveness--who and why?

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum immunoreactive erythropoietin in health and disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subtherapeutic erythropoietin and insulin-like growth factor-1 correct the anemia of chronic renal failure in the mouse

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

INTERFERENCE OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS ON ERYTHROPOIESIS IN KIDNEY TRANSPLANT RECIPIENTS

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac disease in diabetic end-stage renal disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10751750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/(SICI)1520-7560(200003/04)16:2<106::AID-DMRR88>3.0.CO;2-H

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751750%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10751750%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73635381&oldid=1806364412"